A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer
NCT03344614
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
raltitrexed combined with apatinib
Sponsor
Chinese PLA General Hospital